← Eichor
Condition: Circulating Tumor Dna Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Circulating Tumor Dna

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06977074Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
Phase 2 · 7 location(s) · Rutgers, The State University of New Jersey · NCT06518837Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNA
NA · 1 location(s) · University Hospital, Rouen · NCT05375370Circulating Tumor DNA in Stage I, II, and III Germ-Cell Tumors
NA · 1 location(s) · Indiana University · NCT07401316Prognostic Significance of ctDNA in HL
Phase N/A · 5 location(s) · Interni hematologicka klinika FNKV · NCT06263530Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Longitudinal Monitoring MRD Based on ctDNA
Phase N/A · 7 location(s) · Zhujiang Hospital · NCT06157060A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06736613ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx
NA · 2 location(s) · Indiana University · NCT06915038Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
Phase 2 · 7 location(s) · Dana-Farber Cancer Institute · NCT04434040Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Maligna
Phase N/A · 14 location(s) · Tempus AI · NCT07211178CfDNA in Hereditary And High-risk Malignancies 2
Phase N/A · 8 location(s) · University Health Network, Toronto · NCT06726642Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations o
NA · 6 location(s) · Institut Curie · NCT03017573Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer
Phase N/A · 13 location(s) · Swiss Cancer Institute · NCT07617610Monitoring and Early Response Evaluation Using HPV DNA - A Study on Patients With HPV-positive Throat Cancer (MER-HPV)
Phase N/A · 1 location(s) · Region Skane · NCT05649865Selective Internal Radiation Therapy With 90Y Resin Micropheres for Refractory Colorectal Cancer Liver Metastases
Phase N/A · 1 location(s) · Aarhus University Hospital · NCT04491929Study on the Contribution of the Genetic Tumor Profile Obtained by Circulating Tumor DNA Analysis in the Multidisciplina
NA · 1 location(s) · Centre Antoine Lacassagne · NCT06606366ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immuno
Phase 2 · 20 location(s) · Second Xiangya Hospital of Central South University · NCT06951646Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.
Phase N/A · 1 location(s) · Gene Solutions · NCT06167460ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
NA · 1 location(s) · Hua-Jay J Cherng, MD · NCT06693830Detecting HPV DNA in Anal and Cervical Cancers
Phase N/A · 2 location(s) · University of Chicago · NCT04857528Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer
NA · 6 location(s) · Institut Claudius Regaud · NCT06588322Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cance
Phase 3 · 1 location(s) · Fudan University · NCT05954078Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer
Phase N/A · 1 location(s) · Shanghai Pulmonary Hospital, Shanghai, China · NCT05965024Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and
NA · 4 location(s) · Centre Jean Perrin · NCT05710679Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT07524114Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT07516678CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia
Phase N/A · 1 location(s) · Navy General Hospital, Beijing · NCT04157569ctDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer
Phase 2 · 1 location(s) · University of Miami · NCT06902272ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer
Phase 3 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT05815082Circulating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy of PARP Inhibitors (PARPi)
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT05116579
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.